We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
TENT2 is not prognostic in Testicular Germ Cell Tumor (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
9.9
Number of samples
133
Samples
Sample
Description
TPM
TCGA-2G-AAFE-01A
0 years, male, white, stage:Stage IIA, alive, 4702 days
40.6
TCGA-2G-AAHC-01A
0 years, male, white, stage:Stage IS, alive, 5539 days
25.3
TCGA-2G-AAH3-01A
0 years, male, white, stage:Stage I, alive, 1822 days
24.6
TCGA-YU-A90S-01A
0 years, male, white, stage:Stage IA, alive, 971 days
18.2
TCGA-2G-AAHT-01A
0 years, male, white, stage:Stage IS, alive, 542 days
17.9
TCGA-XE-AAOF-01A
0 years, male, asian, stage:Stage IA, alive, 1268 days
17.8
TCGA-S6-A8JW-01A
0 years, male, white, stage:Stage IS, alive, 698 days
17.5
TCGA-2G-AAF1-01A
0 years, male, asian, stage:Stage IS, alive, 1403 days
16.6
TCGA-2G-AAGI-01A
0 years, male, white, stage:Stage IS, alive, 3137 days
16.3
TCGA-ZM-AA0D-01A
0 years, male, white, stage:Stage IA, alive, 848 days
15.9
TCGA-4K-AA1H-01A
0 years, male, white, stage:Stage IA, alive, 518 days
15.9
TCGA-2G-AAH2-01A
0 years, male, white, stage:Stage IS, alive, 6060 days
15.9
TCGA-XE-AANV-01A
0 years, male, stage:Stage IB, alive, 1701 days
15.5
TCGA-YU-A94D-01A
0 years, male, stage:Stage IIIB, alive, 2167 days
15.4
TCGA-2G-AAGG-01A
0 years, male, white, stage:Stage IIIC, alive, 2611 days
15.4
TCGA-WZ-A7V3-01A
0 years, male, white, stage:Stage I, alive, 753 days
15.1
TCGA-2G-AAFJ-01A
0 years, male, asian, stage:'--, alive, 792 days
14.7
TCGA-2G-AAGX-01A
0 years, male, white, stage:Stage IA, alive, 5514 days
14.6
TCGA-SN-A84W-01A
0 years, male, white, stage:Stage IS, alive, 293 days
14.6
TCGA-2G-AAGO-01A
0 years, male, white, stage:Stage IS, alive, 4026 days
14.6
TCGA-2G-AAGP-01A
0 years, male, white, stage:Stage IIA, alive, 4018 days
14.3
TCGA-2X-A9D6-01A
0 years, male, white, stage:Stage I, alive, 607 days
14.1
TCGA-VF-A8AC-01A
0 years, male, white, stage:Stage IA, alive, 1083 days
13.4
TCGA-2G-AAGM-01A
0 years, male, white, stage:Stage IS, alive, 3891 days
13.2
TCGA-2G-AAG0-01A
0 years, male, white, stage:Stage IS, alive, 1529 days
13.2
TCGA-2G-AAEW-01A
0 years, male, white, stage:Stage IS, dead, 618 days
13.1
TCGA-WZ-A7V4-01A
0 years, male, white, stage:Stage I, alive, 894 days
12.8
TCGA-2G-AAG5-01A
0 years, male, white, stage:Stage IS, alive, 2299 days
12.7
TCGA-W4-A7U4-01A
0 years, male, white, stage:'--, alive, 738 days
12.7
TCGA-2G-AAG6-01A
0 years, male, white, stage:Stage IS, alive, 2231 days
12.6
TCGA-2G-AAGY-01A
0 years, male, white, stage:Stage IS, alive, 5329 days
12.4
TCGA-2G-AAGV-01A
0 years, male, white, stage:'--, alive, 4527 days
12.2
TCGA-S6-A8JX-01A
0 years, male, white, stage:Stage IB, alive, 552 days
12.2
TCGA-2G-AAFZ-01A
0 years, male, white, stage:Stage III, alive, 1353 days
12.1
TCGA-YU-A90Y-01A
0 years, male, black or african american, stage:Stage IIIC, dead, 17 days
12.0
TCGA-XY-A89B-01A
0 years, male, white, stage:Stage IA, alive, 471 days
11.9
TCGA-YU-A90Q-01A
0 years, male, stage:Stage IB, alive, 1964 days
11.8
TCGA-2G-AAFG-01A
0 years, male, white, stage:Stage IS, alive, 6183 days
11.6
TCGA-XE-AAOC-01A
0 years, male, white, stage:Stage IA, alive, 270 days
11.5
TCGA-2G-AAL5-01A
0 years, male, white, stage:Stage I, alive, 7437 days
11.5
TCGA-WZ-A7V5-01A
0 years, male, white, stage:Stage I, alive, 1061 days
11.5
TCGA-2G-AAH4-01A
0 years, male, white, stage:Stage II, alive, 6210 days
11.4
TCGA-XE-AANI-01A
0 years, male, white, stage:Stage IS, alive, 1041 days
11.4
TCGA-VF-A8AA-01A
0 years, male, white, stage:Stage I, alive, 1146 days
11.4
TCGA-2G-AAGC-01A
0 years, male, white, stage:Stage IS, alive, 2585 days
11.3
TCGA-2G-AAL7-01A
0 years, male, white, stage:Stage IS, alive, 3991 days
11.2
TCGA-2G-AAH8-01A
0 years, male, white, stage:Stage IIIC, alive, 2248 days
11.1
TCGA-VF-A8AB-01A
0 years, male, black or african american, stage:Stage IA, alive, 760 days
11.1
TCGA-XE-AANR-01A
0 years, male, white, stage:Stage I, alive, 14 days
11.1
TCGA-4K-AA1I-01A
0 years, male, white, stage:Stage IA, alive, 3 days
11.1
TCGA-XY-A9T9-01A
0 years, male, white, stage:Stage IS, alive, 281 days
11.1
TCGA-4K-AAAL-01A
0 years, male, white, stage:Stage IS, alive, 483 days
10.9
TCGA-XE-AANJ-01A
0 years, male, white, stage:Stage IS, alive, 2007 days
10.9
TCGA-2G-AAHA-01A
0 years, male, white, stage:Stage IB, alive, 3349 days
10.8
TCGA-YU-A90P-01A
0 years, male, white, stage:Stage IA, alive, 2069 days
10.8
TCGA-YU-A90W-01A
0 years, male, white, stage:Stage IA, alive, 1113 days
10.8
TCGA-2G-AAF6-01A
0 years, male, white, stage:Stage IS, alive, 3491 days
10.7
TCGA-ZM-AA0E-01A
0 years, male, white, stage:Stage IA, alive, 811 days
10.6
TCGA-XE-AAOD-01A
0 years, male, white, stage:Stage IB, alive, 2058 days
10.6
TCGA-2G-AAG3-01A
0 years, male, white, stage:Stage IS, alive, 1593 days
10.6
TCGA-2G-AAKH-01A
0 years, male, white, stage:Stage II, alive, 6862 days
10.5
TCGA-VF-A8A9-01A
0 years, male, white, stage:Stage IA, alive, 1119 days
10.4
TCGA-2X-A9D5-01A
0 years, male, white, stage:Stage I, alive, 435 days
10.4
TCGA-2G-AAGT-01A
0 years, male, white, stage:Stage IS, alive, 4406 days
10.4
TCGA-ZM-AA0B-01A
0 years, male, white, stage:Stage IA, alive, 838 days
10.4
TCGA-XE-A8H4-01A
0 years, male, white, stage:Stage IA, alive, 559 days
10.3
TCGA-W4-A7U2-01A
0 years, male, white, stage:'--, alive, 1263 days
10.3
TCGA-2G-AAF4-01A
0 years, male, white, stage:Stage I, alive, 2315 days
10.2
TCGA-2G-AAGK-01A
0 years, male, white, stage:Stage IS, alive, 3621 days
10.2
TCGA-WZ-A8D5-01A
0 years, male, white, stage:'--, alive, 774 days
10.1
TCGA-XE-A8H5-01A
0 years, male, stage:Stage IS, alive, 1217 days
10.0
TCGA-2G-AAG7-01A
0 years, male, white, stage:Stage IS, alive, 2475 days
9.8
TCGA-S6-A8JY-01A
0 years, male, white, stage:Stage IS, alive, 278 days
9.7
TCGA-XE-AAOJ-01A
0 years, male, white, stage:Stage IS, alive, 1550 days
9.6
TCGA-2G-AAGE-01A
0 years, male, white, stage:Stage IS, alive, 2478 days
9.3
TCGA-2G-AAGJ-01A
0 years, male, black or african american, stage:Stage IA, alive, 2938 days
9.2
TCGA-2G-AAF8-01A
0 years, male, white, stage:Stage IA, alive, 3911 days
9.0
TCGA-YU-A912-01A
0 years, male, black or african american, stage:Stage IIIC, alive, 866 days
9.0
TCGA-2G-AAKG-01A
0 years, male, white, stage:Stage I, alive, 6598 days
8.9
TCGA-YU-A94I-01A
0 years, male, stage:Stage IA, alive, 536 days
8.9
TCGA-XE-A8H1-01A
0 years, male, white, stage:Stage IS, alive, 209 days
8.8
TCGA-2G-AAFI-01A
0 years, male, white, stage:Stage IB, alive, 675 days
8.8
TCGA-2G-AAH0-01A
0 years, male, white, stage:Stage IS, alive, 5477 days
8.8
TCGA-VF-A8AE-01A
0 years, male, white, stage:Stage IA, alive, 727 days
8.8
TCGA-2G-AAGA-01A
0 years, male, white, stage:Stage IIA, alive, 2439 days
8.6
TCGA-ZM-AA0F-01A
0 years, male, white, stage:Stage IA, alive, 681 days
8.6
TCGA-2G-AAHN-01A
0 years, male, white, stage:Stage I, alive, 6445 days
8.5
TCGA-2G-AAFL-01A
0 years, male, white, stage:Stage IB, alive, 750 days
8.4
TCGA-SB-A6J6-01A
0 years, male, white, stage:Stage IA, alive, 413 days
8.4
TCGA-2G-AAG9-01A
0 years, male, white, stage:Stage IIIB, alive, 2234 days
8.2
TCGA-2G-AAFY-01A
0 years, male, white, stage:Stage IIA, alive, 1099 days
8.2
TCGA-2G-AAFH-01A
0 years, male, white, stage:Stage IIB, alive, 1375 days
8.1
TCGA-VF-A8AD-01A
0 years, male, white, stage:Stage IB, alive, 1006 days
7.9
TCGA-SN-A84X-01A
0 years, male, white, stage:Stage IS, alive, 312 days
7.8
TCGA-XE-AAO4-01A
0 years, male, white, stage:Stage IA, alive, 367 days
7.7
TCGA-XE-AAOB-01A
0 years, male, white, stage:Stage IS, dead, 513 days
7.7
TCGA-XE-AAO3-01A
0 years, male, asian, stage:Stage I, alive, 2857 days
7.7
TCGA-XE-A9SE-01A
0 years, male, white, stage:Stage IA, alive, 708 days
7.5
TCGA-2G-AAHG-01A
0 years, male, white, stage:Stage I, alive, 1819 days
7.2
TCGA-2G-AAFO-01A
0 years, male, white, stage:Stage IIA, alive, 685 days
7.2
TCGA-X3-A8G4-01A
0 years, male, white, stage:Stage IS, alive, 856 days
7.1
TCGA-2G-AALP-01A
0 years, male, white, stage:Stage IIIB, alive, 2645 days
6.9
TCGA-2G-AAGZ-01A
0 years, male, white, stage:Stage IIIA, alive, 5233 days
6.3
TCGA-2G-AAGS-01A
0 years, male, white, stage:Stage IIIB, alive, 4816 days
6.3
TCGA-2G-AAEX-01A
0 years, male, white, stage:Stage IS, alive, 1259 days
6.3
TCGA-SO-A8JP-01A
0 years, male, white, stage:Stage I, alive, 540 days
6.2
TCGA-2G-AAFN-01A
0 years, male, white, stage:Stage IIIB, alive, 773 days
6.2
TCGA-4K-AA1G-01A
0 years, male, white, stage:Stage IS, alive, 436 days
5.9
TCGA-2G-AAGN-01A
0 years, male, white, stage:Stage IIIB, alive, 3656 days
5.9
TCGA-XE-AAO6-01A
0 years, male, white, stage:Stage IA, alive, 240 days
5.9
TCGA-2G-AAHP-01A
0 years, male, white, stage:Stage IS, alive, 5667 days
5.7
TCGA-ZM-AA0H-01A
0 years, male, white, stage:Stage IS, alive, 1736 days
5.6
TCGA-VF-A8A8-01A
0 years, male, white, stage:Stage IA, alive, 1131 days
5.5
TCGA-W4-A7U3-01A
0 years, male, white, stage:'--, alive, 149 days
4.6
TCGA-2G-AAFV-01A
0 years, male, white, stage:Stage IS, alive, 1389 days
4.3
TCGA-2G-AAFM-01A
0 years, male, white, stage:Stage IIA, alive, 503 days
4.2
TCGA-2G-AAKM-01A
0 years, male, white, stage:Stage II, dead, 6972 days
4.0
TCGA-XE-AAOL-01A
0 years, male, black or african american, stage:Stage I, alive, 13 days
4.0
TCGA-2G-AAHL-01A
0 years, male, white, stage:Stage I, alive, 7081 days
3.7
TCGA-2G-AAG8-01A
0 years, male, white, stage:Stage IB, alive, 2289 days
3.6
TCGA-2G-AAKL-01A
0 years, male, white, stage:Stage II, alive, 7023 days
3.4
TCGA-ZM-AA0N-01A
0 years, male, white, stage:Stage IB, alive, 634 days
3.1
TCGA-ZM-AA06-01A
0 years, male, white, stage:Stage IB, alive, 1498 days
2.9
TCGA-SN-A84Y-01A
0 years, male, white, stage:Stage IS, alive, 524 days
2.9
TCGA-XY-A8S2-01A
0 years, male, white, stage:Stage I, alive, 672 days
2.5
TCGA-SN-A6IS-01A
0 years, male, white, stage:Stage IS, alive, 496 days
2.4
TCGA-2G-AAGW-01A
0 years, male, white, stage:Stage IS, alive, 4899 days
2.2
TCGA-2G-AAGF-01A
0 years, male, white, stage:Stage IS, alive, 2734 days
0.0
TCGA-2G-AAKD-01A
0 years, male, white, stage:Stage III, alive, 6340 days
0.0
TCGA-SB-A76C-01A
0 years, male, white, stage:'--, alive, 42 days
0.0
TCGA-YU-AA4L-01A
0 years, male, black or african american, stage:Stage IIIC, alive, 1573 days
0.0
TCGA-ZM-AA05-01A
0 years, male, white, stage:Stage IIC, alive, 1126 days
0.0
TCGA-YU-AA61-01A
0 years, male, white, stage:Stage IS, alive, 864 days
0.0
Show allShow less
TESTIS CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
The Human Protein Atlas project is funded
